Memory Improving and Antidepressant Effects of Topiramate in Rats

Abstract

Topiramate (TOP, CAS 97240-79-4) particularly potentiates γ-aminobutyric acid (GABA) neuroinhibition, and GABA and glutamate receptors, which have also been implicated in memory formation. Patients’ giving up treatment due to adverse effects (disorders of attention, memory, and verbal fluency) is the main problem with a therapy based on this drug. The antidepressant effect of TOP administered to rats in the dose of 15 mg/kg is observed only after 14 and 21 days of treatment. The delay in the antidepressant effect of TOP may be due to the modulation of GABA A receptors as well as due to the influence of the drug on receptors for type AMPA/KAIN excitatory amino acids. The research has also shown that long-term treatment with TOP in a dose of 15 mg/kg improved spatial memory, as tested in rats with Morris test. Probably, this results from the influence of the drug on GABA A receptors and the function of glutaminergic receptors (especially in processes like coding, retrieving, and potentiation of information), adaptive processes in the brain, notwithstanding, being an important factor.

As TOP is a normothymic drug, its use in the treatment of epilepsy may also positively influence cognitive processes in the so-called interseizure intervals with memory disorders; the same effects can be expected in the treatments of bipolar disorder.

Key words

Antiepileptic drug - CAS 97240-79-4 - Memory function - Normothymic drug - Rats - Topiramate, antidepressant effect

• References

• 1 Aldenkamp AP, De Krom M, Rejs R. Newer antiepileptic drugs and cognitive issues. Epilepsia. 2003; 44: 21-9
• 2 Amann B, Grunze H. Neurochemical Underpinnings in Bipolar Disorder and Epilepsy. Epilepsia. 2005; 46: 26-30
• 3 Arnone D. Review of the use of Topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry. 2005; 4: 1-14
• 4 Barton ME, Klein BD, Wolf HH, White HS. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res. 2001; 47: 217-27
• 5 Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol. 2004; 3: 618-21
• 6 Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry. 2002; 63: 15-20
• 7 Berlant JL. Topiramate in posttraumatic stress disorder: preliminary clinical observations. J Clin Psychiatry. 2001; 62: 60-3
• 8 Burton LA, Harden C. Effect of topiramate on attention. Epilepsy Res. 1997; 27: 29-32
• 9 Carlson GA. Bipolar Disorder. In: Martin A, Scahill L, Charney D, Leckman J. editors. W. Pediatric Psychopharmacology. New York (NY): Oxford University Press; 2003: 484-496
• 10 Chengappa KN, Rathore D, Levine J, Atzert R, Solai L, Parepally H et al. Topiramat as add-on treatment for patients with bipolar disorder. Bipolar Disord. 1999; 1: 42-53
• 11 Chengappa KN, Rathore D, Levine J. editors. World Congress of Psychiatry. Presented at the 11th World Congress of Psychiatry; 1999 August 8; Hamburg, Germany.
• 12 Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci. 2004; 5: 4412-20
• 13 Grabowska-Grzyb A. Psychotropowe działanie leków prze-ciwpadaczkowych. Terapia. 2006; 1: 174
• 14 Hargreaves GA, McGregor IS. Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol Clin Exp Res. 2007; 31: 1900-7
• 15 Hoover RC, Motta M, Davis J, Saatman KE, Fujimoto ST, Thompson HJ et al. Differential effects of the anticonvulsant topiramate on neurobehavioral and histological outcomes following traumatic brain in rats. J Neurotrauma. 2004; 21: 501-12
• 16 Husum H, Van Kammen D, Termeer E, Bolwig G, Mathé A. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line ‘depressed’ rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects. Neuropsychopharmacology. 2003; 28: 1292-9
• 17 Kockelmann E, Elger CE, Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res. 2003; 54: 171-8
• 18 Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord. 1998; 50: 245-51
• 19 Martin R, Kuzniecky R, Ho S, Hetherington H, Pan J, Sinclair K et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology. 1999; 52: 321-7
• 20 Martin RC, Griffith HR, Faught E, Gilliam F, Mackey M, Vogtle L. Cognitive functioning in community dwelling older adults with chronic partial epilepsy. Epilepsia. 2005; 46: 298-303
• 21 Martins de Lima MN, Presti-Torres J, Dornelles A, Bromberg E, Schroder N. Differential effects of low and high doses if topiramate on consolidation and retrieval of novel object recognition memory in rats. Epilepsy Behav. 2007; 10: 32-7
• 22 McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus Buspirone SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Dis. 2002; 4: 207-13
• 23 Meador KJ, Loring DW, Ray PG, Murro AM, King DW, Nichols ME et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia. 1999; 40: 1279-85
• 24 Morris R. Development of a water-maze procedure for studying spatial learning in a rat. J Neurosc Methods. 1984; 11: 47-60
• 25 Mula M, Trimble MR, Thompson P, Sander JW. Topiramate and word-finding difficulties in patients with epilepsy. Neurology. 2003; 60: 1104-7
• 26 Nowakowska E, Chodera A, Kus K. An anxiolytic-like effect of ondansetron disappears oxazepam tolerant rats. Pharmacol Biochem Behav. 1998; 59: 935-8
• 27 Nowakowska E, Chodera A, Kus K. Influence of olanzapine on cognitive function and catalepsy in rats after single and chronic administration. Pol J Pharmacol. 1999; 51: 295-300
• 28 Nowakowska E, Kus K, Czubak A, Glowacka D, Matschay A. Some behavioural effects of carbamazepine – comparison with haloperidol. J Physiol Pharmacol. 2007; 58: 253-64
• 29 Ortinski P, Meador KJ. Cognitive side effects on antiepilep-tic drugs. Epilepsy Behav. 2004; 5: 60-5
• 30 Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978; 47: 379-91
• 31 Poulsen CF, Simeone TA, Maar TE, Smith-Swintosky V, White HS, Schousboe A. Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons. Neurochem Res. 2004; 29: 275-82
• 32 Richardson JS, Hertzl L. The effects of antidepressant drugs on adenylyl cyclase linked beta adrenergic binding sites on mouse astrocytes in primary cultures. Prog Neuropsycho-pharmacol Biol Psychiatry. 1983; 7: 675-80
• 33 Sachdeo RC, Reife RA, Lim P. Topiramate monotherapy for partial onset seizure. Epilepsia. 1997; 38: 294-300
• 34 Sankar R, Holmes GL. Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J Child Neurol. 2004; 19: 6-14
• 35 Shannon HE, Eberle EL, Peters SC. Comparison of the effects of antiepileptic drugs with diverse mechanisms of action in the formalin test in rats. Neuropsychopharmacol. 2005; 48: 1012-20
• 36 Shannon HE, Love PL. Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats. Epilepsy Behav. 2005; 7: 620-8
• 37 Shannon HE, Love PL. Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats. Epilepsy Behav. 2004; 5: 857-65
• 38 Stefan H, Feuerstein TJ. Novel anticonvulsant drugs. Pharmacol Therap. 2007; 113: 165-83
• 39 White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 1997; 28: 167-79
• 40 White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia. 2000; 41: 17-20
• 41 Wooten G, Kramer T. eds. World Congress of Psychiatry. Presented at the 11th World Congress of Psychiatry; 1999 August 11; Hamburg, Germany.
• 42 Zaccara G, Messori A, Cincotta M, Burchini G. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?. Acta Neurol Scan. 2006; 114: 157-68
• 43 Zhang X, Velumian AA, Jones OT, Carlen PL. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia. 2000; 41: 52-60
• 44 Zona C, Ciotti MT, Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cell. Neurosc Letters. 1997; 231: 123-6